"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
(tranexamic acid) Injection
- Patient Information:
Details with Side Effects
Each mL of the sterile solution for intravenous injection contains 100 mg tranexamic acid and Water for Injection to 1 mL.
Chemical Name: trans-4-(aminomethyl)cyclohexanecarboxylic
acid Structural Formula:
Empirical Formula: C8H15NO2 Molecular Weight: 157.2
Tranexamic acid is a white crystalline powder. The aqueous solution for injection has a pH of 6.5 to 8.0.
What are the possible side effects of tranexamic acid (Cyklokapron, Lysteda)?
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop taking tranexamic acid and call your doctor at once if you have a serious side effect such as:
- problems with your vision (including color vision);
- sudden numbness or weakness, especially on one side of the body;
- sudden headache, confusion, problems with vision, speech, or balance;
- sudden chest pain or trouble breathing;
- pain or swelling in one or both...
Last reviewed on RxList: 6/3/2013
This monograph has been modified to include the generic and brand name in many instances.
Additional Cyklokapron Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.